Clinical Trial

Clinical Evaluation of the Adaptilens Accommodating IOL

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goals of this feasibility study are to learn more about the performance of the intraocular lens (IOL), if the IOL is safe for use, and what the best surgical techniques are for implanting the IOL in patients who require correction of aphakia following phacoemulsification extraction of a senile cataract.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-22.
Trial Details
NCT Number NCT07607860
Lead Sponsor Adaptilens, Inc.
Conditions Aphakia Cataract
Enrollment 100 participants
Start Date 2026-09
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-06